Global virus network launches multi-country mpox diagnostic evaluation to close global preparedness gaps

Through its Mpox Action Committee and Centers of Excellence, GVN has initiated one of the first coordinated, multi-country evaluations of rapid point-of-care mpox diagnostics, a critical step to prevent resurgence and ensure the world is better prepared for future epidemics. GVN’s coordinated effort spans four countries and includes leading scientists from Emory University (USA), the University of St Andrews (UK), the Institute of Human Virology Nigeria, and the University of Health Sciences Otukpo (Nigeria). Teams are comparing rapid diagnostic kits against gold-standard PCR assays, testing their performance on real clinical samples, and analyzing operational feasibility in resource-limited settings.

Sophia Osawe, MPH, PhD, head of department research operations and senior research manager at the Institute of Human Virology Nigeria, a GVN Center of Excellence, is leveraging her team’s biorepository of mpox samples to compare diagnostic kits under ISO-accredited lab conditions.

Read more: https://gvn.org/global-virus-network-launches-multi-country-mpox-diagnostic-evaluation-to-close-global-preparedness-gaps/